Stocks
Funds
Screener
Sectors
Watchlists
PNT

PNT - POINT Biopharma Global Inc. Stock Price, Fair Value and News

$76.38-1.76 (-2.25%)
Market Closed

Price Targets

PNT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PNT Price Action

Last 7 days

-7.4%

Last 30 days

-7.6%

PNT RSI Chart

PNT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PNT Valuation

PNT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

PNT Fundamentals

PNT Revenue

PNT Earnings

PNT Profitability

PNT Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20230000
2022000226.6M
PNT
POINT Biopharma Global Inc., a radiopharmaceutical company, develops and commercializes radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-alpha inhibitor targeting program being developed for use in various tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.
 CEO
 WEBSITEpointbiopharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES129

POINT Biopharma Global Inc. Frequently Asked Questions


PNT is the stock ticker symbol of POINT Biopharma Global Inc.. Every public company that trades on a stock exchange gets a ticker symbol.